Successful management of coronary artery perforation with helical platinum microcoil embolization

M S Aslam1, R N Messersmith, J Gilbert

  • 1Division of Cardiology, Lutheran General Hospital, Park Ridge, Illinois 60068, USA. heartdoc20@hotmail.com

Insights

Microcoil embolization successfully treated small coronary artery perforation during intervention, even with ongoing leakage possibly due to glycoprotein IIB/IIIA inhibitors. This technique avoided surgery for a high-risk patient.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Coronary artery perforation is a rare but serious complication during percutaneous coronary intervention.
  • Management strategies for coronary artery perforation vary depending on severity and hemodynamic stability.
  • Glycoprotein (GP) IIB/IIIA inhibitors are frequently used during high-risk interventions, potentially increasing bleeding risk.

Observation:

  • A case of small coronary artery perforation occurred during a coronary intervention procedure.
  • Prolonged intracoronary balloon inflation was insufficient to control continued leakage from the perforation site.
  • The leakage was potentially exacerbated by the concurrent use of glycoprotein IIB/IIIA inhibitors.

Findings:

  • Microcoil embolization was employed as a minimally invasive technique to manage the coronary artery perforation.
  • The microcoil embolization procedure was technically successful in sealing the perforation.
  • No adverse sequelae were observed following the successful embolization.

Implications:

  • Microcoil embolization represents a viable and effective treatment option for select cases of coronary artery perforation.
  • This technique can help avoid more invasive surgical procedures, particularly in high-risk patients.
  • Successful management of coronary perforation with embolization preserves cardiac function and reduces patient morbidity.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: